Safety and efficacy of automatic subcutaneous injection of daratumumab via an infusion pump

Int J Hematol. 2024 Nov 23. doi: 10.1007/s12185-024-03885-y. Online ahead of print.

Kazuhito Suzuki¹, Riku Nagao^{2

3}, Tadahiro Gunji², Masaharu Kawashima², Hideki Uryu², Mika Terada⁴, Kayo Namiki⁴, Kaichi Nishiwaki^{2

3}, Shingo Yano²

¹ Division of Clinical Oncology/Hematology, Department of Internal Medicine, The Jikei University School of Medicine, 3-25-8 Nishi-Shimbashi, Minato-ku, Tokyo, 105-0003, Japan. [email protected].
² Division of Clinical Oncology/Hematology, Department of Internal Medicine, The Jikei University School of Medicine, 3-25-8 Nishi-Shimbashi, Minato-ku, Tokyo, 105-0003, Japan.
³ Division of Clinical Oncology/Hematology, Department of Internal Medicine, The Jikei University Kashiwa Hospital, Chiba, Japan.
⁴ Nursing Department, The Jikei University Hospital, Tokyo, Japan.

No abstract available

Keywords: Automatic subcutaneous injection; Daratumumab; Infusion pump; Multiple Myeloma.

Publication types